Last reviewed · How we verify
Placebo Inhaltion Powder — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Inhaltion Powder (Placebo Inhaltion Powder) — GlaxoSmithKline. A placebo inhalation powder that contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Inhaltion Powder TARGET | Placebo Inhaltion Powder | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Inhaltion Powder CI watch — RSS
- Placebo Inhaltion Powder CI watch — Atom
- Placebo Inhaltion Powder CI watch — JSON
- Placebo Inhaltion Powder alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Inhaltion Powder — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-inhaltion-powder. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab